Skip to content

Home-based exercise program for individuals post-Covid-19

Telerehabilitation for individuals post-Covid-19

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-75g56jn
Enrollment
Unknown
Registered
2025-11-27
Start date
2023-05-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long Covid

Interventions

A total of 36 individuals will participate in this study. The 24 volunteers interested in telerehabilitation will be randomized in parallel (1:1) through the website http://www.randomization.com into

Sponsors

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul - FAPERGS
Lead Sponsor
Universidade Federal de Santa Maria
Collaborator

Eligibility

Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Individuals who had COVID-19; present persistent fatigue symptoms; if hospitalized, they must have been discharged more than four weeks ago; aged over 18 and up to 59 years; of both sexes; clinically stable; able to use a computer or smartphone, or have someone to assist them; and have access to a smartphone or computer with an internet connection

Exclusion criteria

Exclusion criteria: Individuals with severe cognitive impairments; individuals with uncorrectable vision problems (even with glasses); with uncorrectable hearing impairments (even with hearing aids); immobility or inability to walk (due to trauma or conditions requiring bed rest); those using assistive walking devices; with diagnosed severe pulmonary hypertension; pre-Covid pulmonary or neuromuscular disease; hemodynamic instability; fever; unstable angina; uncontrolled seizure disorders; postural hypotension; balance problems (score of zero for standing position and feet-together stance on the Short Physical Performance Battery); individuals currently undergoing physical training; those using CPAP (continuous positive airway pressure) for sleep apnea treatment; those with untreated laryngeal or thyroid disease; who have undergone respiratory or head and neck surgery; who currently or previously worked as voice professionals or have been intubated; those with unstable heart disease; diagnosed fibromyalgia; or spirometry-confirmed obstructive ventilatory disorder

Design outcomes

Primary

MeasureTime frame
An increase in functional capacity, assessed by the distance covered in the 6-minute walk test, is expected, with a difference of 75 m in favor of the TA + TR group associated with TMI compared to the TA + TR group associated with TMI-SHAM;A greater reduction in fatigue, as assessed by the Chalder Fatigue Scale, is expected in the TA + TR group combined with TMI compared to the TA + TR group combined with TMI-SHAM;A greater reduction in dyspnea, as assessed by the modified Medical Research Council Scale, is expected in the TA + TR group combined with TMI compared to the TA + TR group combined with TMI-SHAM

Secondary

MeasureTime frame
An increase in inspiratory muscle strength, measured by maximum inspiratory pressure, is expected to be greater in the TA + TR group associated with TMI compared to the TA + TR group associated with TMI-SHAM;An increase in inspiratory muscle endurance, assessed by the duration of the resisted inspiration test at 60% of maximum inspiratory pressure, is expected to be greater in the TA + TR group associated with TMI compared to the TA + TR group associated with TMI-SHAM;An improvement in cardiovascular autonomic control, as measured by the high-frequency component of heart rate variability, is expected to be greater in the TA + TR group associated with TMI compared to the TA + TR group associated with TMI-SHAM;It is expected that there will be a greater reduction in fatigue of the knee extensor muscles, as determined by isokinetic dynamometer, in the TA + TR group associated with TMI compared to the TA + TR group associated with TMI-SHAM;An improvement in the architecture and elastography of the vastus lateralis muscle, assessed by ultrasound, is expected to be greater in the TA + TR group associated with TMI compared to the TA + TR group associated with TMI-SHAM;A greater reduction in the vocal disadvantage index, as determined through a questionnaire, is expected in the TA + TR group associated with TMI compared to the TA + TR group associated with TMI-SHAM;An increase in maximum phonation time, measured through pitch sustain and loudness, is expected to be greater in the TA + TR group associated with TMI compared to the TA + TR group associated with TMI-SHAM

Countries

Brazil

Contacts

Public ContactCarine Callegaro

Universidade Federal de Santa Maria

carine.callegaro@ufsm.br+55(55)3220-8234

Outcome results

None listed

Source: REBEC (via WHO ICTRP)